Zemplar (paricalcitol injection)

DRUG3 trials

Sponsors

Abbott, Genzyme, a Sanofi Company

Conditions

End-Stage Kidney DiseaseSecondary Hyperparathyroidism

Phase 4

Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis

TerminatedNCT00062699

AbbottEnd-Stage Kidney Disease

Start: 2003-04-30Target: 2200Updated: 2006-08-02

A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis

CompletedNCT00454350

Genzyme, a Sanofi CompanySecondary Hyperparathyroidism

Start: 2007-02-28End: 2007-07-31Target: 12Updated: 2015-05-05

A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection

CompletedNCT00463021

Genzyme, a Sanofi CompanySecondary Hyperparathyroidism

Start: 2007-04-30End: 2007-12-31Target: 36Updated: 2015-05-05